Andrew Left recently revealed a short position in Palantir, citing its huge valuation.Since then, his firm, Citron Research, ...

Short-seller Andrew Left is betting against Palantir amid a stunning 144% rally in the shares in 2025. Left says the ...

Andrew Left argues that investors have overhyped Palantir stock, and its valuation pales in comparison to a true AI leader ...

Short-seller Citron targets Palantir, arguing the AI stock is overvalued. Find out why OpenAI's valuation suggests a ...

Palantir’s dramatic stock moves followed fresh fire from short-sellers, particularly Citron Research, led by Andrew Left. In ...

Most stocks are rallying today after Federal Reserve Chair Jerome Powell hinted at a September interest rate cut in a speech ...

Short-seller Citron targets PLTR again, using a Databricks comparison to argue the stock is overvalued after its report sent ...

Then, short seller Andrew Left of Citron Research said PLTR stock was "detached from fundamentals and analysis". He's ...

Rishi Jaluria of RBC Capital Management, a subsidiary of the Royal Bank of Canada, has a $45 price target on Palantir's stock ...

Palantir stock has been on a rough run, slipping for the fifth straight session and now sitting 12% below its recent all-time ...

Palantir’s fundamentals remain strong, with commercial segment driving exponential growth, outpacing government contracts.